?:authorAffiliation
|
-
[\'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.\', \'Division of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.\', \'The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of .Oslo, Oslo, Norway.\', \'SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.\', \'Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.\', \'Department Clinical Interventions and Technology CLINTEC, Division for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.\', \'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. niklas.bjorkstrom@ki.se.\']
|